CorVel Corp. 10-Q Summary: Quarter Ended June 30, 2003
Business Context and Reporting Period
This Form 10-Q covers the three-month period ended June 30, 2003. CorVel Corporation provides managed care services, primarily focusing on workers' compensation claims management, medical bill review, and diagnostic imaging services. The company operates in a regulated environment subject to state licensing and evolving healthcare legislation.
Key Financial Metrics
| Metric | Q2 2003 | Q2 2002 |
|---|---|---|
| Revenues | $75,912,000 | $66,301,000 |
| Gross Profit | $13,608,000 | $12,310,000 |
| Gross Margin | 17.9% | 18.6% |
| Net Income | $4,357,000 | $4,029,000 |
| Diluted EPS | $0.40 | $0.36 |
| Operating Cash Flow | $8,970,000 | $4,386,000 |
| Cash and Equivalents (End of Period) | $5,454,000 | $8,468,000 |
| Total Assets | $95,633,000 | $93,325,000 (Mar 31, 2003) |
| Working Capital | $35,177,000 | $37,513,000 (Mar 31, 2003) |
Note: The filing does not explicitly state total debt figures, but notes a $5 million credit facility with no borrowings outstanding as of June 30, 2003.
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 14.5% year-over-year, driven primarily by a 21.4% increase in provider program revenues (bill review, PPO, and diagnostic services). This was bolstered by the full quarter contribution from the AnciCare acquisition and the introduction of the CorcareRX program.
- Margin Compression: Gross margin decreased from 18.6% to 17.9%. Management attributes this to a higher mix of CorcareSelect services (independent medical exams and MRI), which carry a higher cost of revenue percentage compared to bill review services.
- Cash Flow Improvement: Operating cash flow more than doubled to $9.0 million, aided by improved Days Sales Outstanding (DSO) in accounts receivable (dropping from 54 to 51 days).
- Share Repurchases: The company repurchased 91,000 shares for $3.0 million during the quarter, continuing its long-term buyback program.
Outlook, Risks, and Unusual Items
- Acquisitions: CorVel acquired Scan One, a document management and scanning provider, at the end of the quarter. The impact on Q2 revenue and income was negligible, but the company expects synergies with its medical bill review processing.
- Liquidity: Working capital decreased by $2.3 million due to the Scan One acquisition and share repurchases. Management believes current cash, operating cash flow, and the $5 million credit facility are sufficient for the next 12 months.
- Risks: Key risks include potential adverse impacts from government regulation (licensing requirements, legislative reforms in workers' compensation), competition from larger insurers and HMOs, and dependence on key personnel. The company also notes that slower growth in the national labor market and workers' compensation claims has historically dampened revenue growth.
- Forward-Looking Statements: Management cautions that past performance is not indicative of future results and that actual outcomes may differ due to economic conditions and regulatory changes.
Investor Verification Checklist
- Revenue Mix Sustainability: Verify if the shift toward higher-cost diagnostic services (CorcareSelect) will continue to pressure gross margins.
- Acquisition Integration: Monitor the financial contribution of the Scan One and AnciCare acquisitions in subsequent quarters to ensure projected synergies materialize.
- Regulatory Environment: Track state-level legislative changes regarding workers' compensation and managed care licensing that could increase operational costs or limit service offerings.
- Capital Allocation: Assess the balance between continued share repurchases and the capital required for future growth or acquisitions.
- DSO Trends: Confirm that the improvement in Days Sales Outstanding is sustainable and not a temporary anomaly.